CD4 and neoplasm: Accordingly, an increase in CD44hiCD62Llow/− effector T cells was detected in both CD4+ and CD8+ T cell populations in mice vaccinated with CD47KO tumor cells compared to those immunized with PBS or WT tumor cells (Supplementary Fig. 2b).